Baclofen in Parkinson's disease
- PMID: 355602
- PMCID: PMC1083385
- DOI: 10.1136/jnnp.41.8.707
Baclofen in Parkinson's disease
Abstract
In a controlled trial, baclofen (mean dose 45 mg daily) signficantly increased disability from Parkinsonism in 12 patients with the long-term levodopa syndrome. Peak dose choreoathetosis was not improved but benefit was observed in all four patients with "off period dystonia." Adverse side effects were common and severe, and included visual hallucinations, vomiting, and dizziness.
Similar articles
-
Effect of baclofen on tardive dyskinesia.Psychopharmacology (Berl). 1978 Mar 1;56(2):145-51. doi: 10.1007/BF00431840. Psychopharmacology (Berl). 1978. PMID: 417365 Clinical Trial.
-
The relationship between parkinsonism and tardive dyskinesia.Am J Psychiatry. 1977 Jul;134(7):781-4. doi: 10.1176/ajp.134.7.781. Am J Psychiatry. 1977. PMID: 869056
-
Sodium valproate in the treatment of levodopa-induced dyskinesia.J Neurol Neurosurg Psychiatry. 1978 Aug;41(8):702-6. doi: 10.1136/jnnp.41.8.702. J Neurol Neurosurg Psychiatry. 1978. PMID: 355601 Free PMC article. Clinical Trial.
-
Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.Drugs. 2016 May;76(7):759-77. doi: 10.1007/s40265-016-0566-3. Drugs. 2016. PMID: 27091215 Review.
-
Ropinirole: a review of its use in the management of Parkinson's disease.Drugs. 2000 Jul;60(1):115-37. doi: 10.2165/00003495-200060010-00007. Drugs. 2000. PMID: 10929932 Review.
Cited by
-
Anti-parkinsonian drugs today.Drugs. 1984 Sep;28(3):236-62. doi: 10.2165/00003495-198428030-00002. Drugs. 1984. PMID: 6435991 Review.
-
Gamma-aminobutyric acid(B) receptor activation suppresses stimulus-evoked burst firing in rat substantia nigra reticulata neurons.Neuroreport. 2012 Jan 4;23(1):40-4. doi: 10.1097/WNR.0b013e32834e4899. Neuroreport. 2012. PMID: 22127013 Free PMC article.
-
Aetiology and natural history of Parkinson's disease.Br Med J. 1978 Dec 16;2(6153):1664-6. doi: 10.1136/bmj.2.6153.1664-a. Br Med J. 1978. PMID: 32952 Free PMC article. Review. No abstract available.
-
Parkinson's disease treatment: past, present, and future.J Neural Transm (Vienna). 2020 May;127(5):785-791. doi: 10.1007/s00702-020-02167-1. Epub 2020 Mar 14. J Neural Transm (Vienna). 2020. PMID: 32172471 Free PMC article. Review.
-
CSF and plasma GABA levels in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1982 Mar;45(3):253-6. doi: 10.1136/jnnp.45.3.253. J Neurol Neurosurg Psychiatry. 1982. PMID: 7086446 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources